Clinical Research Directory
Browse clinical research sites, groups, and studies.
Hepatitis C in Prison: Study of Screening and Rapid Treatment (HEPAPRIS)
Sponsor: Assistance Publique - Hôpitaux de Paris
Summary
Due to the high prevalence of HCV in prison and the risk of transmission between inmates, the management of hepatitis C and its treatment must be optimal following the recommendations of AFEF. The purpose of this study is to assess the treatment starting delay from the date of incarceration of inmates with chronic HCV infection (hepatitis C).
Official title: Hepatitis C in Prison: Study of Rapid Diagnosis and Treatment
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
0
Start Date
2023-01
Completion Date
2025-07
Last Updated
2026-05-06
Healthy Volunteers
No
Conditions
Interventions
Xpert® HCV Viral test
an additional sample of 5 ml of blood will be taken for real-time HCV PCR by Xpert®, in addition to the blood samples taken as part of routine care.
FibroScan® test
A non invasive test made on a small area of skin coated with a gel
Locations (1)
Internal Medicine Service, Cochin Hospital (Consultation and Ambulatory Care Unit (UCSA) within the Paris-La Santé Penitentiary Center (CPPLS))
Paris, France